← Back to Clinical Trials
Recruiting NCT05214365

Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy

Trial Parameters

Condition Conduction System Pacing
Sponsor Hospital Clinic of Barcelona
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2022-02-01
Completion 2025-09-01
Interventions
Pacemaker implantation and conventional cardiac pacingConduction system pacing implant

Brief Summary

The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.

Eligibility Criteria

Inclusion Criteria: * The patient must be ≥ 18 years of age. * The patient must indicate their acceptance to participate in the study by signing an informed consent document. * Patients with EF\> 50% and indication for pacemaker implantation due to atrial-ventricular block according to current clinical guidelines. Exclusion Criteria: * Inability to understand and sign the informed consent. * Patients with severe comorbidities and life expectancy \<1 year. * Patients with severe cognitive impairment or other comorbidities resulting in dependence for basic activities of daily life. * Patients who cannot come to our center to carry out the follow-up of the study.

Related Trials